The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for treating adults with growth hormone deficiency (GHD).This ...

One high profile case of growth hormone deficiency is soccer player Lionel Messi. He received a GH deficiency diagnosis at 11 years old when doctors told his family without hormone therapy he ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few ...

The Food and Drug Administration has approved Skytrofa ® (lonapegsomatropin-tcgd) to treat patients 1 year of age and older weighing at least 11.5kg and have a growth failure due to inadequate ...

The Food and Drug Administration (FDA) has approved Ngenla ™ (somatrogon-ghla), a once-weekly, human growth hormone analog for the treatment of pediatric patients 3 years of age and older who ...

The recommended dose of SKYTROFA for treatment-naïve children with growth hormone deficiency and those switching from daily somatropin is 0.24 mg/kg body weight, administered once weekly. [2] ...

The once-weekly growth hormone analog somapacitan (Sogroya, Novo Nordisk) has been given the green light in both Europe and the United States for the treatment of children and adolescents with ...

Growth hormone use is exploding among pre-teens with wealthy parents seeking out a fast growth solution for kids who don't measure up to their peers. Getty Images/iStockphoto There’s no expense ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally ...